Outcome and Recurrence in Treatment of Phimosis Using Topical Betamethasone in Children in Hong Kong
Overview
Authors
Affiliations
Aim: To study the efficacy of treating phimosis with topical steroid, and its long-term outcome and side effects. We also looked into the effect of daily retraction and cleansing of prepuce on preventing recurrence of phimsosis.
Methods: This prospective study comprised 138 boys who were prescribed 0.05% betamethasone ointment (Diprocel) during 1 August 2001-31 July 2004. Five boys were excluded because of non-compliance. Of the remaining 133 boys, 108 were followed-up and assessed. Age ranged from 0.03 to 12.9 years (mean=3.38, SD=2.79). The number of treatment course received, short-term and long-term outcome, side effects and the effect of daily foreskin retraction were studied.
Results: The success rate of first treatment course was 81.5%, and 60.2% of boys remained free from phimosis upon latest assessment. The follow-up period ranged from 0.4 to 4.4 years (mean=2.45, SD=0.90). There were no side effects noted. We found a significant and linear relationship between daily foreskin retraction and sustained resolution of phimosis.
Conclusion: Topical steroid is an effective and safe treatment for phimosis, especially when combined with a good hygiene practice of the foreskin with daily cleansing and retraction. A trial of topical steroid treatment should be offered upon considering circumcision.
Zhou G, Yin J, Sun J, Zhu W, Jin S, Li S Front Pediatr. 2022; 10:1025899.
PMID: 36389352 PMC: 9664212. DOI: 10.3389/fped.2022.1025899.
Zhou G, Jiang M, Yang Z, Xu W, Li S J Paediatr Child Health. 2021; 57(12):1960-1965.
PMID: 34212436 PMC: 9290972. DOI: 10.1111/jpc.15628.
Dave S, Afshar K, Braga L, Anderson P Can Urol Assoc J. 2018; 12(2):E76-E99.
PMID: 29381458 PMC: 5937400. DOI: 10.5489/cuaj.5033.
[Circumcision for boys incapable of giving informed consent].
Schramm F, Gierthmuhlen S, Eckstein A, Schmidt A, Bloch M Urologe A. 2009; 48(8):869-73.
PMID: 19626309 DOI: 10.1007/s00120-009-2059-4.